Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. More about the company

₹101.5
-1.28% today
₹738 Cr · Small cap
Market Neutral — FadingHealth Care 40.6% in Stage 2-7.4 pts / 20dHospitals & Diagnostic Centres 19.4%-19.4 pts

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

Steady

Edge

—

Is GAUDIUMIVF early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
—
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 33
1w13w26w
Week 33 — mature, watch for distribution
How long this stock has been basing. Longer bases can produce stronger breakouts — but don't anticipate, wait for the breakout.
vs 200 DMA
—
—
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.53x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↓
MA20 rolling over · -4.8% vs MA50 -9.6%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-12.8%
3M
-29.4%
6M
-2.6%
YTD
—
1Y
—
Sector
Health Care
↓ Peaking
Stage 2%
40.6%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Sector has 67 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
19.4%
20d Δ
-19.4pp
1M return
-10.4%
3M return
-12.2%
Industry Stage-2 % · last 20 days
Industry has 5 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →
Stage Cycle Timeline2026-02-27 → 2026-10-16
S? 33w
2026-02-272026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 33w current
Total tracked: 33 weeks across 1 stage run.
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-16S—
Wk 33 · Vol 0.53x
2026-10-15S—
Wk 32 · Vol 0.60x
2026-10-14S—
Wk 32 · Vol 0.72x
2026-10-13S—
Wk 32 · Vol 0.63x
2026-10-12S—
Wk 32 · Vol 0.34x
2026-10-09S—
Wk 32 · Vol 0.87x
2026-10-08S—
Wk 31 · Vol 0.96x
2026-10-07S—
Wk 31 · Vol 0.50x
2026-10-06S—
Wk 31 · Vol 2.02x
2026-10-05S—
Wk 31 · Vol 4.69x
2026-10-01S—
Wk 31 · Vol 1.66x
2026-09-30S—
Wk 30 · Vol 1.33x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹115.7
200 DMA
—
52W High
—
52W Low
—
5D Low
₹101.5
Resistance levels (recent highs)
20d High
₹117.7
60d High
₹155
120d High
₹158.2
250d High
—
Next resistance
+16.0%
to 20d High
Ask the Market AI about GAUDIUMIVFAsk →
P/E (TTM)
35.2
Forward —
Earnings Growth (YoY)
+7.3%
Revenue +69.9%
About this companyHealth Care· Hospitals & Diagnostic Centres

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; infertility surgeries; egg freezing; surrogacy; and laparoscopic and hysteroscopic surgeries for the diagnosis and treatment of infertility-related conditions, as well as offers genetic testing options, including preimplantation genetic testing (PGT); and IVF consultancy services. In addition, the company operates hospital, in-house pharmacy; and 7 hubs (IVF centers) and 28 spokes. The company was founded in 2009 and is based in headquartered in New Delhi, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.